Two days of arm rest may reveal why muscles weaken faster in type 2 diabetes
NCT ID NCT06750497
First seen Jul 02, 2026 ยท Last updated Jul 02, 2026
Summary
This study investigates how two days of forearm immobilization (keeping the arm in a cast or sling) changes the way muscles take up glucose and amino acids. Researchers will compare these effects in people with type 2 diabetes and healthy volunteers. The goal is to understand why muscle insulin sensitivity drops so quickly during short periods of inactivity, especially in those with diabetes.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- forearm immobilization
- What this could lead to
- If successful, this could help explain why muscle weakness and insulin resistance develop quickly in people with type 2 diabetes after short periods of inactivity.
- What could go wrong
- This is a small, early-stage study (26 participants) that only looks at short-term effects. Results may not apply to longer periods of inactivity or to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wageningen University and Research
RECRUITINGWageningen, Gelderland, 6708WD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will a syringe and a vial deliver the same obesity drug dose?
- Can a new injectable drug pass its first human safety test?
- Could a simple questionnaire transform diabetes consultations?
- Can exercise rewire bone strength? a new trial investigates
- Daily pill could offer new hope for weight loss in east asian adults
- Could a new oral drug change future treatments? early safety trial begins